Q3 2025 Earnings Call Transcript November 13, 2025 Bionano Genomics, Inc. beats earnings expectations. Reported EPS is ...

Revenue Guidance -- Management reiterated full-year fiscal 2025 revenue guidance of $26 million to $30 million and set Q4 ...

NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced that it will be ...

Bionano Genomics, Inc. ( BNGO) Q3 2025 Earnings Call November 13, 2025 4:30 PM EST Good day, and welcome to the Bionano Third Quarter 2025 Earnings Conference Call. Today's conference is being ...

Jaipur: Even though the recent information bulletin for the NEET PG counselling in Rajasthan revealed a uniform MD, MS fee ...

Clinical Outcomes -- Twelve-month study data for the Catamaran implant showed VAS scores decreased from 78.8 to 23, and ODI ...

Many factors contribute to dementia, of course. But the role of particulates - microscopic solids or droplets in the air - is drawing closer scrutiny. Particulates arise from many sources: emissions ...

This article explores how epigenetic mechanisms control gene expression, how their disruption drives cancer and how targeting ...

Germania Insurance will partner with the Gulf Coast Regional Blood Center to host a community blood drive on Wednesday, Dec. 3, from 10 a.m. to 2:30 p.m. at the company’s ...

Check stock performance, fundamentals, market cap, shareholding, financial reports, annual & quarterly results, and profit & loss statements.